Главная › Немелкоклеточный рак легкого › Северная Каролина › Durham
Клинические исследования Немелкоклеточный рак легкого в городе Durham, NC
39 исследований по теме Немелкоклеточный рак легкого ищут участников в центрах в городе Durham и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набор участниковФаза 3
- Duke University Medical Center, Durham
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Набор участниковФаза 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 миль отсюда
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набор участниковФаза 1/2
- Duke University, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набор участниковФаза 1
- Exelixis Clinical Site #12, Durham
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Набор участниковФаза 3
- UNC Lineberger Comprehensive Cancer Center ( Site 3250), Chapel Hill · 10 миль отсюда
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набор участниковФаза 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набор участниковФаза 3
- Duke Cancer Center, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- PHN-012-001 Site, Durham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Набор участниковФаза 3
- UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 миль отсюда
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Набор участниковФаза 3
- Duke University Medical Center, Durham
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 миль отсюда
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Набор участниковФаза 1/2
- Duke Cancer Center Durham, Durham
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набор участниковФаза 3
- Clinical Study Site, Durham
- Clinical Study Site, Chapel Hill · 10 миль отсюда
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Набор участниковФаза 3
- Durham VA Health Care System, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набор участниковФаза 1/2
- Duke University School of Medicine, Durham
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набор участниковФаза 2/3
- Duke University Medical Center, Durham
Effects of Infusion Timing on Treatment Response in Solid Tumors
Набор участниковФаза 2
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 миль отсюда
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Набор участниковНаблюдательное исследование
- UNC- Chapel Hill, Chapel Hill · 10 миль отсюда
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набор участниковФаза 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набор участниковФаза 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 миль отсюда
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Набор участниковФаза 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 миль отсюда
- University of North Carolina, Chapel Hill · 10 миль отсюда
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Набор участниковФаза 1/2
- Duke Cancer Institute, Durham
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Набор участниковФаза 2
- UNC Health - University of North Carolina, Chapel Hill · 10 миль отсюда
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Набор участниковФаза 1
- Duke University Medical Center, Durham
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Набор участниковФаза 1/2
- Duke Cancer Institute, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Duke Cancer Center, Durham
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Набор участниковФаза 2
- University of North Carolina, Chapel Hill · 10 миль отсюда
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Набор участниковФаза 1
- Duke Cancer Institute /ID# 276267, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набор участниковФаза 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Набор участниковФаза 1
- Duke Cancer Center /ID# 251975, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Durham VA Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набор участниковФаза 1
- Duke Cancer Center, Durham
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2/3
- Durham VA Medical Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Набор участников
- Durham VA Medical Center, Durham, NC, Durham
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Набор участниковРанняя фаза 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 миль отсюда
GEMINI-NSCLC: NSCLC Biomarker Study
Набор участниковНаблюдательное исследование
- Duke University, Durham
- UNC, Chapel Hill · 10 миль отсюда
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 миль отсюда
A Study of NX-1607 in Adults With Advanced Malignancies
Набор участниковФаза 1
- University of North Carolina, Chapel Hill · 10 миль отсюда
Исследования Немелкоклеточный рак легкого в других городах
- Houston, TX145 исследований
- New York City, NY121 исследование
- Arlington, VA104 исследований
- Nashville, TN97 исследований
- Boston, MA90 исследований
- Los Angeles, CA87 исследований
- St. Louis, MO73 исследований
- Chicago, IL61 исследование
- Baltimore, MD60 исследований
- San Antonio, TX59 исследований
- Columbus, OH57 исследований
- Washington, DC55 исследований
Другие исследования в городе Durham
- Рак молочной железы64 исследований
- Рак (все виды)58 исследований
- Множественная миелома37 исследований
- Острый миелоидный лейкоз33 исследований
- Метастатический рак33 исследований
- Рак простаты32 исследований
- Рак легких32 исследований
- Колоректальный рак28 исследований
- Рак яичников27 исследований
- Хронический лимфоцитарный лейкоз27 исследований
- Сердечная недостаточность26 исследований
- Рак поджелудочной железы24 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.